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The purpose of this study was to develop a new solvent-displacement (nanoprecipitation) method [1] based on a 
micro-engineered membrane with a regular array of uniform pores to tailor the size of biodegradable and 
bioresorbable drug-loaded polymeric nanoparticles (NPs). Polycaprolactone (PCL) was chosen as a Food and 
Drug Administration (FDA) approved drug carrier, commonly applied in pharmaceutical industry [2] due to its 
slow degradation rate and biocompatibility, while acetone (Ace) was used as a water-miscible volatile organic 
solvent (ICH, Class 2) [3]. A natural macrocyclic lactone, rapamycin (RAPA) which is also known as a potent 
immunosuppressive agent [4] was used in the encapsulation experiment and drug release study. Nanoparticles 
were produced instantaneously by fast solvent switching once the organic phase was injected through the 
membrane pores into a stirred aqueous phase. The organic phase was made up of 0.3 − 0.6 % (w/w) PCL in 
Ace and the aqueous phase was consisted of 1 % (w/w) polyvinylalcohol (PVA) dissolved in Milli-Q water. The 
cell was filled with 20 − 60 ml of the aqueous phase and the organic phase was injected until a predetermined 
aqueous phase to organic phase volume ratio, Vaq/Vor was achieved. The parameters that have been varied in 
the experiments were: (i) organic phase injection rate (2-5 ml/min), (ii) agitation speed of the stirrer (200-1300 
rpm) and (iii) final volume ratio, Vaq/Vor (1.5, 3.0, 4.5, 7.0, and 10.0). The membrane had uniform cylindrical 
pores with a diameter of 10, 20 and 40 μm, arranged at a uniform spacing of 200 μm. The experimental set-up is 
depicted in Fig. 1. The nanoparticles were produced with a mean size of 156−276 nm depending on the shear 
stress at the membrane surface controlled by the stirring speed and other parameters. The physical 
characterisations of formulated nanoparticles were determined by X-ray diffractometry (XRD), differential 
scanning calorimetry (DSC) and Attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy. 
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Figure 1 – (a) A 
photomicrograph of 10 μm 
nickel micro-engineered 
membrane. (b) Schematic 
diagram of the 
experimental setup used in 
this work. (c) TEM image of 
RAPA-PCL encapsulated 
nanoparticles. (d) TEM 
image of RAPA- without 
PCL NPs host.  
 
